Osman ÜÇÜNCÜ, Murat KÜÇÜK, Nurettin YAYLI, Emine AKYÜZ, Ahmet YAŞAR, Alpay Şengül KARAOĞLU, Nuran YAYLI

Synthesis and biological acitivities of N-alkyl derivatives of o-,m-, and p-nitro (E)-4-azachalcones and stereoselective photochemistry in solution, with theoretical calculations

The N-alkyl derivatisation and photochemical dimerisation of 3 o-, m-, and p-nitro substituted 4-azachalcones (1-3) yielded 3 new o-, m-, and p-nitro substituted (.E)-N-decyl-4-azachalconium bromides, (2E)-1-(2-nitrophenyl)-3-(N—decyl-4-pyridmium bromide)-2-propen-1-one (4), (2E)-1-(3-nitrophenyl)-3-(N-decyl-4-pyridinium bromide)-2-propen-1-one (5), and (2E)-1-(4-nitrophenyl)-3-(N-decyl-4-pyridinium bromide)-2-propen-1-one (6), and 3 new dimers in solution, $(1beta,2alpha)$-di-(3-nitrobenzoyl)-$(3beta,4alpha)$-di-(4-pyridinyl)cyclobutane (7), $(1beta,2alpha)$-di-(4-nitrobenzoyl)-$(3beta,4alpha)$-di-(4-pyridinyl)cyclobutane (8a), and $(1beta,2alpha)$-di-(4-nitrobenzoyl)-$(3beta,4alpha)$-di-(4-pyridinyl)cyclobutane (8b), stereoselectively. The monomeric compounds showed good antimicrobial activity against test micro-organisms. The most sensitive microorganisms were Gram-positive bacteria. The monomers also showed high antioxidant activity, while the dimerisation products 7-8a,b were less active. Compound 6 was found to have similar or even higher activity when compared to the standard antipxidants Trolox and vitamin C, respectively. The possible dimerisation products of compounds 1-3 were calculated theoretically. Experimental and theoretical calculations showed that5-truxinic type dimer is the most stable isomer.

PDF

___

1. J.B. Harborne, “The Flavonoids, Advances in Research”, Chapman & Hall, New York NY, 329-388, 1988.
2. J.P.J. Marais, D. Ferreira and D. Slade, Phytochemistry 66, 2145-2176 (2005).
3. Z. Nowakowska, E. Wyrzykiewicz and B. Kedzia, Il Farmaco 56, 325–329 (2001).
4. M.L. Edwards, D.M. Stemarick, J.S. Sabol, K.A. Diekema and R.J. Dinerstein, J. Med. Chem. 37, 4357-4362 (1994).
5. M. D’Auira and R. Racioppi, Tetrahedron 53, 17307-17316 (1997).
6. M. D’Auria, L. Emanuele, V. Esposito and R. Racioppi, Arkivoc (xi), 65-78 (2002).
7. M. D’Auria, Heterocycles, 54, 475-496 (2000).
8. M. D’Auria, L. Emanuele, G. Mauriello and R. Racioppi, J. Photochem. Photobiol. A, 134, 147-154 (2000).
9. N. Yaylı, A. Yaşar, O. Üçüncü, S. Ö. Sivrikaya, C. Güleç, M. Küçük and R. Abbasov, J. Photochem. Photobiol. A, 175, 291-298 (2005).
10. N. Yaylı, O. Üçüncü, A. Yaşar, Y. Gök, M. Küçük and S. Kolaylı, Turk. J. Chem., 28, 515-521 (2004).
11. N. Yaylı, O. Üçüncü, E. Aydın, Y. Gök, A. Yaşar, C. Baltacı, N. Yıldırım and M. Küçük, J. Photochem. Photobiol. A, 169, 229-234 (2005).
12. V. Seidel, F. Bailleul and P.G. Waterman, Phytochemistry 55, 439-446 (2000).
13. D.R. Katerere, A.I. Gray, A.R. Kennedy, R.J. Nash and R.D. Waigh, Phytochemistry 65, 433-438 (2004).
14. M. D’Auria and R. Racioppi, J. Photochem. Photobiol. A, 112, 145-148 (1998).
15. J. Durinda, L. Szucs, J. Kolena, A. Nagy, E. Misikova and J. Heger, Czech. Cesko-Slov. Farmac. 26, 140-149 (1977).
16. V.L. Aeppli, K. Bernuuer, F. Schneider, K. Strub, W.E. Oberhansli and K.H. Pfoertner, Helv. Chim. Acta 63, 630-644 (1980).
17. Z. Zhang, Y.W. Dong and G.W. Wang, Chem. Lett. 32, 966-967 (2003).
18. Z. Nowakowska, E. Wyrzykiewicz and B. Kedzia, Il Farmaco 57, 657–661 (2002).
19. Z. Nowakowska, Magn. Reson. Chem. 38, 382–383 (2000).
20. B.Z. Jovanovic, M.M. Vukovic, A.D. Marinkovic and J. Csanadi, J. Mol. Struct. 482-483, 371-374 (1999).
21. National Committee for Clinical Laboratory Standard, NCCLS Document M7-A3, 13 (25), Willanova, PA., USA, 1993.
22. M. Cuendet, K. Hostettmann and O. Potterat, Helv. Chim. Acta 80, 1144-1152 (1997).